Welcome to UCL

Four in five patients with early and intermediate-stage rectal cancer could be spared life-changing surgery by giving them a combination of chemotherapy and radiotherapy, a UCL-led trial has found.

New research from UCL and UCLH suggests that prostate cancer in some men can be identified from an MRI scan with a very high degree of confidence, potentially reducing the need for a biopsy.

Writing in the Financial Times, UCL President and Provost Michael Spence comments on London's Knowledge Quarter and its proximity to UCL, highlighting it as an innovation powerhouse.

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.

Semi-transparent solar cells that could be added to windows to efficiently harvest energy from indoor light as well as the sun have been developed by an international team led by UCL researchers.

Early results from a UCL and UCLH-led clinical trial suggest that a type of CAR T-cell therapy - developed by Autolus Therapeutics, a UCL spinout - could offer a new treatment approach for people with severe, treatment-resistant lupus.

Professor Ibrahim Abubakar, UCL’s Vice-Provost (Health), will become the new CEO of CEPI, the Coalition for Epidemic Preparedness Innovations, the leading global partnership for pandemic preparedness.

Professor Jacqui Glass, Dean of the UCL Bartlett Faculty of the Built Environment and a leading expert in construction and the built environment, has been appointed interim Vice-Provost (Faculties) at UCL.

Three UCL academics have been appointed as Fellows of the British Academy, in recognition of their contribution to the humanities and social sciences.